Young plasma ameliorates aging-related acute brain injury after intracerebral hemorrhage

Jun-Jie Yuan1, Qin Zhang1, Chang-Xiong Gong1

  • 1Department of Neurology, Xinqiao Hospital, The Army Medical University, Third Military Medical University, Chongqing 400037, China.

Bioscience Reports
|May 2, 2019
PubMed

Insights

Young plasma therapy shows promise for acute brain injury in aging rodents. It reduced mortality and neurological deficits, potentially by increasing insulin-like growth factor 1 (IGF-1) levels, offering a novel therapeutic avenue.

Area of Science:

  • Neuroscience
  • Gerontology
  • Regenerative Medicine

Background:

  • Aging impairs brain function and worsens acute brain damage.
  • Young plasma has shown potential to reverse age-related decline in biofunctions.
  • Intracerebral hemorrhage (ICH) is a severe form of acute brain injury often exacerbated by aging.

Purpose of the Study:

  • To investigate the neuroprotective effects of young plasma in aging rodents with ICH.
  • To identify circulating factors in young plasma that may mediate these protective effects.
  • To explore the role of insulin-like growth factor 1 (IGF-1) in aging-related brain injury and its response to young plasma.

Main Methods:

  • Administration of young plasma to aging ICH rodent models.
  • Assessment of mortality, neurological deficit scores, brain water content, and neuronal survival.
  • Proteomics analysis to identify differential circulating factors between age groups.
  • Enzyme-linked immunosorbent assay (ELISA) to quantify IGF-1 levels in plasma and brain tissue.
  • Administration of IGF-1 to aging ICH rodents to evaluate its therapeutic effect.

Main Results:

  • Young plasma significantly reduced mortality and neurological deficits in aging ICH rodents.
  • Proteomics revealed age-dependent changes in plasma factors, with IGF-1 notably decreased in older individuals.
  • Young plasma treatment restored decreased brain IGF-1 levels in aging ICH rats.
  • Direct administration of IGF-1 ameliorated acute brain injury in aging ICH rodents.

Conclusions:

  • Young plasma possesses neuroprotective properties against acute brain injury in aging.
  • Circulating factors, particularly IGF-1, transferred via young plasma may exert therapeutic effects.
  • Young plasma represents a potential novel therapeutic strategy for age-related acute brain injury.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
642
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
982
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
426
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
314
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
863
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
287